Zevia PBC (ZVIA) Tops Q3 EPS by 2c ; Offers Guidance

Zevia PBC (NYSE: ZVIA) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $39.26 million.

GUIDANCE:

Zevia PBC sees Q4 2025 revenue of $39-41 million, versus the consensus of $40.31 million.

Zevia PBC sees FY2025 revenue of $162-164 million, versus the consensus of $162 million.

For earnings history and earnings-related data on Zevia PBC (ZVIA) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance